Cross Country Healthcare, Inc. (CCRN)

Jul 21, 2026 - CCRN was delisted (reason: acquired by Knox Lane)

13.25

0.00 (0.00%)

Inactive · Last trade price on Jul 20, 2026

Cross Country Healthcare Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	105.58	108.74	81.63	17.09	3.6	1.04
Cash & Short-Term Investments	105.58	108.74	81.63	17.09	3.6	1.04
Cash Growth	30.84%	33.20%	377.55%	374.31%	247.88%	-35.25%
Accounts Receivable	176.64	167.51	223.24	372.35	641.61	493.91
Other Receivables	7.41	4.34	11.57	9.51	12.06	0.3
Receivables	184.05	171.86	234.81	381.86	653.67	494.21
Prepaid Expenses	7.41	7.56	7.85	7.68	11.07	7.65
Other Current Assets	1.26	5.43	10.71	10.24	7.33	5.38
Total Current Assets	298.3	293.59	335	416.88	675.67	508.27
Property, Plant & Equipment	29.09	29.98	31.32	29.94	22.93	23.38
Goodwill	63.8	63.8	135.06	135.43	163.27	119.49
Other Intangible Assets	40.91	41.66	53.03	60.46	49.18	53.08
Long-Term Deferred Tax Assets	-	-	8.1	5.98	7.09	11.53
Long-Term Deferred Charges	0.79	0.99	1.81	2.62	3.44	0.99
Other Long-Term Assets	18.17	18.92	24.93	29.76	26.26	16.07
Total Assets	451.07	448.95	589.25	681.06	947.84	732.81

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	47.6	2.04	5.74	3.04	12.86	3.14
Accrued Expenses	39.52	53.02	69.06	68.24	99.66	80.48
Current Portion of Long-Term Debt	-	-	-	-	-	4.18
Current Portion of Leases	0.97	1.16	2.09	2.6	4.13	4.09
Current Income Taxes Payable	-	-	-	-	-	7.31
Other Current Liabilities	2.47	21.53	43.51	82.19	154.98	100.58
Total Current Liabilities	90.57	77.76	120.4	156.08	271.64	199.77
Long-Term Debt	-	-	-	-	148.74	176.37
Long-Term Leases	1.07	1.16	1.78	2.66	4.88	10.85
Long-Term Deferred Tax Liabilities	2.7	2.52	0.57	0.4	0.25	0.19
Other Long-Term Liabilities	43.93	44.7	47.54	54.27	65.12	48.1
Total Liabilities	138.27	126.13	170.29	213.41	490.62	435.28

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	195.55	201.17	202.34	236.42	292.88	321.55
Retained Earnings	118.94	123.21	218.06	232.62	165.73	-22.74
Comprehensive Income & Other	-1.69	-1.56	-1.44	-1.39	-1.39	-1.29
Total Common Equity	312.81	322.82	418.96	467.65	457.22	297.53
Shareholders' Equity	312.81	322.82	418.96	467.65	457.22	297.53
Total Liabilities & Equity	451.07	448.95	589.25	681.06	947.84	732.81

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2.04	2.32	3.87	5.27	157.75	195.49
Net Cash (Debt)	103.54	106.42	77.76	11.83	-154.14	-194.45
Net Cash Growth	33.80%	36.85%	557.50%	-	-	-
Net Cash Per Share	3.21	3.28	2.33	0.33	-4.11	-5.20
Filing Date Shares Outstanding	32.33	32.32	32.81	34.73	36.82	38.06
Total Common Shares Outstanding	31.24	31.72	32.28	34.38	36.3	37.02
Working Capital	207.73	215.83	214.6	260.8	404.03	308.5
Book Value Per Share	10.01	10.18	12.98	13.60	12.59	8.04
Tangible Book Value	208.09	217.36	230.87	271.77	244.77	124.95
Tangible Book Value Per Share	6.66	6.85	7.15	7.90	6.74	3.37
Machinery	-	3.55	3.92	6.41	8.72	7.86
Construction In Progress	-	7.87	1.13	1	3.46	2.52
Leasehold Improvements	-	0.06	0.37	1.21	2.65	4.34

SEC Filings: 10-K · 10-Q